Market Announcements 2021
MARCH 2021
31 March – New United States Patent Granted for Patrys’ Deoxymab Assets
FEBRUARY 2021
10 February – Patrys Successfully Establishes PAT-DX1 Stable Cell Line
DEOXYMAB 3E10 INTRODUCTION
DEOXYMAB 3E10 PLATFORM
31 March – New United States Patent Granted for Patrys’ Deoxymab Assets
10 February – Patrys Successfully Establishes PAT-DX1 Stable Cell Line